You can meet us at RSNA in Chicago December 1–5, 2024, to discuss quantitative MRI and introduce our new and advanced technology— ANDI.

An independent article titled “Predicting recovery in patients with mild traumatic brain injury and a normal CT using serum biomarkers and diffusion tensor imaging (CENTER-TBI): an observational cohort study” was recently published in eClinicalMedicine, part of The Lancet Discovery Science.

July 31, 2023—Imeka, the leading neuroimaging company combining diffusion imaging and AI to map white matter microstructure, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its Advanced Neuro Diagnostic Imaging (ANDI) quantitative imaging software.

April 5, 2022—GE Healthcare will integrate Imeka’s non-invasive neuroimaging technology into the BrainWave advanced diffusion processing package to allow researchers and clinicians to analyze diffusion MRI signals in the brain in greater detail.

An independent scientific article about ANDI has been published in BMC Neurology by Dr. Cyrus Raji and his team from the Washington School of Medicine.